Search
LifeMD Inc
LFMDAdd to Watchlist
2.195USD
+0.540+32.63%
Close 11-12 16:00（ET）
105.80MMarket Cap
32.45P/E TTM
LifeMD Inc (LFMD) Stock Price Target & Forecast
Analyst Rating
Based on 8 analysts giving stock ratings to LifeMD Inc in the past month.
Buy
1 Strong Buy
7 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
8.125USD+254.80%
LFMD Analyst Recommendation Trends
In the current month, LFMD has received 7 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. LFMD average Analyst price target in the last month is 8.125.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
1
1
1
1
7
7
7
7
7
7
7
6
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8
8
8
8
8
8
8
8
LFMD Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Intuitive Surgical Inc
ISRG
11
13
9
1
0
34
Boston Scientific Corp
BSX
7
15
11
0
0
33
Edwards Lifesciences Corp
EW
10
14
6
0
0
30
Thermo Fisher Scientific Inc
TMO
10
17
3
0
0
30
Veeva Systems Inc
VEEV
8
13
7
1
0
29
Danaher Corp
DHR
11
13
3
0
0
27
Waters Corp
WAT
8
10
8
0
0
26
Agilent Technologies Inc
A
6
11
7
0
0
24
GE Healthcare Technologies Inc
GEHC
6
10
7
0
0
23
Resmed Inc
RMD
3
8
10
1
1
23
Financial Forecasting
Based on analysts' estimates, LFMD EPS is projected to reach 0.023 in FY2026Q4, following reported EPS of -0.109 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.22
-0.15
-0.14
0.02
-0.04
Actual
-0.20
-0.16
-0.11
--
--
Surprise
+8.18%
-12.89%
+23.01%
--
--
FAQs
What is LifeMD Inc's expected revenue for the next quarter?
LifeMD Inc's expected revenue is 61.32M.
What is LifeMD Inc's price target?
Analysts forecast that LifeMD Inc's price target is USD 8.12, with the highest forecast at USD 15.00 and the lowest forecast at USD 5.00.
How have LifeMD IncLFMD's recent earnings per share performed?
The market expectation was USD -0.11, while LifeMD IncLFMD's earnings per share (EPS) for the previous quarter was USD -0.16. EPS for the next quarter is expected at USD 0.02.
What is the analyst rating for LifeMD Inc?
Based on the ratings of LifeMD Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.